Skip to content

Other ways to search: Events Calendar | UTHSC News

Malignant Hematology

The UTHSC Cancer Program has a comprehensive malignant hematology treatment team comprised of hematologists, hemato-pathologists, pharmacists and specialized nursing care. This team coordinates multidisciplinary care with other specialties such as radiation oncology, bone marrow transplant, nutrition and surgery to facilitate diagnosis and the best treatment plans. The hematologists specialize in the treatment of common forms of blood cancers such as acute leukemias, myelodysplastic syndrome, chronic leukemias, myeloma and lymphoma. The team also provides expert care for rare forms of blood disorders such as amyloidosis, T-cell lymphoma/leukemia, histiocytic disorders, aplastic anemia and other bone marrow failure conditions. By application of modern targeted therapies, clinical trial participation opportunities and cancer genome sequencing technology we aim to provide personalized and cutting-edge treatment to our patients in Memphis and the surrounding areas. The UTHSC malignant hematology team prioritizes patient health and wellbeing and provides the best treatment options and key supported care throughout UTHSC and its affiliated hospitals.

Specialists

Hematology Oncology Specialists

 

altText

Noura Elsedawy, MD
Assistant Professor
Myeloma Specialist

 

altText

Muhammad Hamid, MD
Assistant Professor
Lymphoma Specialist

 

altText

Swapna Thota, MD
Assistant Professor
Leukemia Specialist

Pathology Specialists

 

altText

Abdallah Azouz, MD
Assistant Professor


 

altText

Joel F. Gradowski, MD
Assistant Professor


 

altText

Lauren Cooper King, MD
Assistant Professor


Contact Us

Medical Oncology

UTHSC Cancer Program
901.448.3469
19 S. Manassas, Memphis, TN 38103
heme_onc@uthsc.edu

May 26, 2022